HardwareNorth Vancouver, CanadaFounded 2015· One of 1757 Hardware companies tracked by AMPulse
Develops ultra-fast DLP 3D printers using Intelligent Liquid Interface (ILI) technology for photopolymer printing, targeting medical and engineering applications.
CEO / Founder
Brian Rock
Team Size
1-10
Stage
Active
Total Funding
$12.5M
Latest Round
Venture Round
Key Investors
PBYVentures
Technology & Products
Key Products
NP1 DLP 3D Printer; NP1-L DLP 3D Printer
Technological Advantage
Proprietary ILI process enables 30% faster printing than competitors, with verified speeds printing a full-sized skull in minutes vs hours; defensible through R&D and membrane formulations.
Differentiation
Value Proposition
Reduces 3D printing time by up to 150x compared to traditional SLA and 40x vs PolyJet, enabling rapid production of anatomical models and end-use parts for surgical planning and prototyping.
How They Differentiate
3x faster than traditional DLP/SLA printers (55 mm in 4.3 min vs 18+ hours for FDM), with ILI technology reducing pull force vs competitors' oxygen or pneumatic systems; focuses on medical applications with Henkel/BASF material partnerships.
Market & Competition
Target Customers
Medical device manufacturers, hospitals, universities, engineering firms
Industry Verticals
Medical; Engineering; Education
Competitors
NEXA3D; Carbon3D; HP (Multi Jet Fusion)
Growth & Milestones
Growth Metrics
Annual revenue was $4 million in 2025
Major Milestones
2015: Founded and ILI technology development; 2016: Showcased at CES with fast printing demos; 2018: NP1 printer commercially available; 2020: Partnership with Henkel for medical 3D printing
Notable Customers
Formula UBC Racing; Stanford University; University of Washington; University of Louisville
NewPro3D addresses the speed bottleneck in photopolymer additive manufacturing with its Intelligent Liquid Interface (ILI) technology. Unlike conventional DLP or SLA systems that rely on mechanical peeling or oxygen-based release layers, ILI uses a transparent wettable membrane to eliminate slow separation steps, achieving vertical print speeds of 55 mm in 4.3 minutes — roughly 150x faster than traditional SLA and 40x faster than PolyJet processes.
The company's NP1 and NP1-L DLP printers are designed for medical device manufacturers, hospitals, and engineering firms. Verified applications include printing full-sized anatomical skulls for surgical planning in minutes versus hours, enabling same-day clinical workflows. Academic customers such as Stanford University, University of Washington, and University of Louisville use the systems for research and prototyping, while Formula UBC Racing applies them to engineering end-use parts.
NewPro3D competes in the fast photopolymer segment against NEXA3D and Carbon, but claims a 3x speed advantage over typical DLP/SLA printers due to reduced pull forces from the ILI membrane. Material partnerships with Henkel (Loctite Additive Manufacturing) and BASF broaden its resin compatibility for medical-grade and engineering polymers. The company's IP portfolio covers the ILI process and membrane formulations, providing a defensible position against larger competitors like HP's Multi Jet Fusion.
Founded in 2015 and based in North Vancouver, NewPro3D has raised $12.5 million from PBYVentures and reported $4 million in annual revenue for 2025. With a team of 1-10 employees, the company remains an emerging player in polymer AM, where scaling production capacity and expanding beyond academic and medical niches into serial production will determine its long-term competitive trajectory.